Glycosaminoglycan Recognition by YKL-40: Potential Regulation in Disease

YKL-40 (CHI3L1) is a secreted chitinase-like protein involved in inflammation, tissue remodeling, angiogenesis, and cancer. Although its biological activities have been extensively investigated, the molecular mechanisms regulating its extracellular interactions remain incompletely understood. YKL-40 binds several glycosaminoglycans (GAGs), including heparin (hep), heparan sulfate (HS), dermatan sulfate (DS), and hyaluronan (HA). YKL-40-GAG interactions are influenced by the GAG chain length, sulfation, and uronic acid composition, suggesting that YKL-40 selectively recognizes specific structural features of GAG chains rather than electrostatic interactions alone. YKL-40 is known to interact with the HS-containing cell-surface receptors CD44v3, syndecan-1, and syndecan-4, which have been implicated in YKL-40-mediated signaling associated with tumor progression and angiogenesis. Because HS structures are dynamically regulated through sulfation and the C5-epimerization of D-glucuronic acid (GlcA) to L-iduronic acid (IdoA), pathological remodeling may alter the binding properties of HS chains of these receptors. This hypothesis-driven review examines the structural determinants of YKL-40-GAG recognition and proposes a mechanism by which disease-associated changes in HS sulfation, the uronic acid composition, and motif organization could alter YKL-40 binding affinity for HS-containing receptors, potentially influencing their downstream signaling. However, whether such remodeling directly alters YKL-40 binding or signaling remains to be experimentally established. Understanding how receptor-associated HS structures influence YKL-40 recognition may provide new insights into its context-dependent biological activity and potential therapeutic targeting.

Authors

Institutions

Publication Details

Journal
Biomolecules
Published
2026-11-13
DOI
https://doi.org/10.3390/biom16111659
Primary Topic
Proteoglycans and glycosaminoglycans research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Glycosaminoglycan Recognition by YKL-40: Potential Regulation in Disease

Jens Guðmundur Hjörleifsson, Kristinn Ragnar Óskarsson, Jón M. Einarsson, Finnbogi Rutur Thormodsson et al.
3 links
Biomolecules
Proteoglycans and glycosaminoglycans research
article

Glycosaminoglycan Recognition by YKL-40: Potential Regulation in Disease

Jens Guðmundur Hjörleifsson, Kristinn Ragnar Óskarsson, Jón M. Einarsson, Finnbogi Rutur Thormodsson, Unnur Magnusdottir
article en

Abstract

YKL-40 (CHI3L1) is a secreted chitinase-like protein involved in inflammation, tissue remodeling, angiogenesis, and cancer. Although its biological activities have been extensively investigated, the molecular mechanisms regulating its extracellular interactions remain incompletely understood. YKL-40 binds several glycosaminoglycans (GAGs), including heparin (hep), heparan sulfate (HS), dermatan sulfate (DS), and hyaluronan (HA). YKL-40-GAG interactions are influenced by the GAG chain length, sulfation, and uronic acid composition, suggesting that YKL-40 selectively recognizes specific structural features of GAG chains rather than electrostatic interactions alone. YKL-40 is known to interact with the HS-containing cell-surface receptors CD44v3, syndecan-1, and syndecan-4, which have been implicated in YKL-40-mediated signaling associated with tumor progression and angiogenesis. Because HS structures are dynamically regulated through sulfation and the C5-epimerization of D-glucuronic acid (GlcA) to L-iduronic acid (IdoA), pathological remodeling may alter the binding properties of HS chains of these receptors. This hypothesis-driven review examines the structural determinants of YKL-40-GAG recognition and proposes a mechanism by which disease-associated changes in HS sulfation, the uronic acid composition, and motif organization could alter YKL-40 binding affinity for HS-containing receptors, potentially influencing their downstream signaling. However, whether such remodeling directly alters YKL-40 binding or signaling remains to be experimentally established. Understanding how receptor-associated HS structures influence YKL-40 recognition may provide new insights into its context-dependent biological activity and potential therapeutic targeting.

BiomoleculesVol. 16(11)
University of Iceland (IS), University of Akureyri (IS)
Proteoglycans and glycosaminoglycans research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon